Minerva Surgical, Inc. provided Revenue guidance for 2022. For the period, the company expects which is unchanged from the guidance given during the previous quarter, with annual revenue anticipated to be between $50 million and $53 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | -.--% | -.--% | -99.91% |
03/01 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index | CI |
2023 | Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.91% | 8.88K | |
-4.81% | 11.09B | |
-1.95% | 8.56B | |
+40.43% | 5.62B | |
-27.04% | 4.41B | |
+7.47% | 3.41B | |
-15.26% | 2.6B | |
-12.01% | 2.07B | |
-13.56% | 1.92B | |
-29.81% | 1.63B |
- Stock Market
- Equities
- UTRS Stock
- News Minerva Surgical, Inc.
- Minerva Surgical, Inc. Provides Revenue Guidance for 2022